Jean-Pierre Raynaud
Overview
Explore the profile of Jean-Pierre Raynaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neuzillet Y, Raynaud J, Dreyfus J, Radulescu C, Rouanne M, Schneider M, et al.
Eur Urol Oncol
. 2024 Aug;
PMID: 39209681
Background And Objective: Failure rates after first-line treatment of localized prostate cancer (PCa) treatment remain high; therefore, it is essential to improve the selection and identification of at-risk patients to...
2.
Pattou M, Neuzillet Y, Raynaud J, Radulescu C, Fiet J, Giton F, et al.
Fr J Urol
. 2024 Jun;
34(7-8):102659.
PMID: 38825320
Background: Advances in chromatography and mass spectrometry have allowed us to develop a novel technique for measuring intraprostatic hormone concentrations directly on prostate needle biopsies, rather than using traditional punch...
3.
Neuzillet Y, Dreyfus J, Raynaud J, Rouanne M, Schneider M, Roupret M, et al.
Asian J Androl
. 2021 Mar;
23(5):520-526.
PMID: 33762475
This study aims to investigate whether clinical and biological preoperative characteristics of patients who were to undergo radical prostatectomy were associated with impairment in patient-reported quality of life (QoL) and...
4.
Neuzillet Y, Rouanne M, Dreyfus J, Raynaud J, Schneider M, Roupret M, et al.
Asian J Androl
. 2021 Feb;
23(4):370-375.
PMID: 33565427
Robust data evaluating the association of preoperative parameters of the patients with quality of life after radical prostatectomy are lacking. We investigated whether clinical and biological preoperative characteristics of the...
5.
Meunier M, Neuzillet Y, Dreyfus J, Schneider M, Roupret M, Cathelineau X, et al.
World J Urol
. 2021 Feb;
39(8):2945-2951.
PMID: 33521883
Purpose: PSA is known to be lowered in obese patients. There is a lack of data regarding patients with prostate cancer. Our objective was to prospectively assess the relationship PSA...
6.
Meunier M, Neuzillet Y, Raynaud J, Radulescu C, Ghoneim T, Fiet J, et al.
Prostate
. 2018 Oct;
79(3):272-280.
PMID: 30370569
Background: Currently, there is no consensus regarding the expected concentration levels of intra-prostatic sex steroids in patients with Prostate Cancer (PCa). Our objective was to assess the concentration levels of...
7.
Neuzillet Y, Raynaud J, Dreyfus J, Radulescu C, Rouanne M, Schneider M, et al.
Horm Cancer
. 2018 Oct;
10(1):36-44.
PMID: 30293206
Failure rates after first-line treatment of localized prostate cancer (PCa) treatment remain high. Improvements to patient selection and identification of at-risk patients are central to reducing mortality. We aimed to...
8.
Neuzillet Y, Raynaud J, Radulescu C, Fiet J, Giton F, Dreyfus J, et al.
Prostate
. 2017 Sep;
77(15):1512-1519.
PMID: 28905453
Background: The specific involvement of the sex steroids in the growth of the prostatic tissue remains unclear. Sex steroid concentrations in plasma and in fresh surgical samples of benign central...
9.
Neuzillet Y, Raynaud J, Lebret T, Pichon A, Radulescu C, Molinie V, et al.
Horm Mol Biol Clin Investig
. 2015 Jun;
22(3):101-9.
PMID: 26047422
Purpose: To compare histological features of prostate cancer according to both obesity, defined by a body mass index (BMI) ≥30 kg/m2, and androgenic status in patients who underwent radical prostatectomy....
10.
Raynaud J, Colle M, Pujos-Gautraud M, Lemaire A, Auzerie J, Gardette J
Horm Mol Biol Clin Investig
. 2015 May;
2(3):301-9.
PMID: 25961202
Objective: To compare mean serum total testosterone, bioavailable-testosterone, and dihydrotestosterone levels between transdermal testosterone and oral testosterone undecanoate treatment. Methods: Multicentre, randomized, cross-over study; 44 men >18 years, testosterone ≤2.5 ...